Skip to main content
. 2022 Jun 21;22:684. doi: 10.1186/s12885-022-09774-z

Table 2.

Univariate and multivariate analyses for overall survival of GC patients (N = 615)

Parameters Univariate analysis Multivariate analysis
HR 95%CI P value HR 95%CI P value
Gender 1.188 0.86–1.64 0.296
Age 1.723 1.317–2.255  < 0.001 1.936 1.467–2.555  < 0.001
ALI 0.571 0.438–0.744  < 0.001 0.75 0.567–0.992 0.044
LPR 11.208 7.541–16.658  < 0.001 5.619 3.503–9.013  < 0.001
Tumor size 1.154 1.114–1.196  < 0.001 1.068 1.015–1.124 0.012
Tumor location
 proximal stomach 1  < 0.001 0.444
 distal stomach 0.684 0.504–0.929 0.015 0.255
 full stomach 1.393 0.952–2.037 0.088 0.302
Histology 0.792 0.591–1.06 0.117
TNM stage
 I 1 1  < 0.001
 II 2.16 1.068–4.37 0.032 2.843 1.323–6.107 0.007
 III 7.277 4.364–12.134  < 0.001 7.626 3.937–14.774  < 0.001
Chemotherapy 2.432 1.769–3.344  < 0.001 0.455 0.305–0.68  < 0.001

HR Hazard ratio, CI Confidence interval, ALI Advanced lung cancer inflammation index, LPR Lymph node positive rate on biopsy, TNM Tumor-node-metastasis. ALI was grouped according to cutoff value (39.77) obtained from ROC curve. The reference of gender, age, ALI, tumor location, histology and TNM stage was male, age < 65 years, low ALI, proximal stomach, undifferentiated and TNM stage I, respectively. LPR was analyzed as a continuous variable in univariate or multivariate analysis